These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6416698)

  • 41. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 42. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
    Delzotto L; Viggiano G; Marchini M; Barbui PE
    Minerva Med; 1977 Jun; 68(28):1957-60. PubMed ID: 406584
    [No Abstract]   [Full Text] [Related]  

  • 43. Epirubicin in treatment and recurrence prophylaxis of patients with superficial bladder cancer.
    Burk K; Kurth KH; Newling D
    Prog Clin Biol Res; 1989; 303():423-34. PubMed ID: 2780657
    [No Abstract]   [Full Text] [Related]  

  • 44. [Primary superficial bladder carcinoma. Prognostic factors for recurrence].
    Jiménez Cruz JF; Llopis Minguez B; Vera Donoso CD
    Arch Esp Urol; 1990; 43 Suppl 2():139-47. PubMed ID: 2096775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural history and treatment of low and high risk superficial bladder tumors.
    Rübben H; Lutzeyer W; Fischer N; Deutz F; Lagrange W; Giani G
    J Urol; 1988 Feb; 139(2):283-5. PubMed ID: 3339726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy of bladder tumours.
    Pavone-Macaluso M
    Urol Res; 1978; 6(4):259-62. PubMed ID: 105444
    [No Abstract]   [Full Text] [Related]  

  • 47. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group.
    Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Maru A; Matsumura Y; Niijima T; Obata K; Ohe H
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S91-6. PubMed ID: 3117403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemotherapy of bladder cancer: a review.
    Smith PH
    Cancer Treat Rep; 1981; 65 Suppl 1():165-73. PubMed ID: 6799197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status of intravesical chemotherapy trials in the EORTC Urological Group. An overview.
    Denis L; Bouffioux C; Kurth KH; Debruyne F; Sylvester R; De Pauw M
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S67-71. PubMed ID: 3664947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
    Colombo R
    Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 53. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.
    Sylvester RJ; Oosterlinck W; van der Meijden AP
    J Urol; 2004 Jun; 171(6 Pt 1):2186-90, quiz 2435. PubMed ID: 15126782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
    Horn Y; Eidelman A; Walach N; Yuval E; Markowitz A
    J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer.
    Niijima T; Koiso K; Akaza H
    Cancer Chemother Pharmacol; 1983; 11 Suppl():S79-82. PubMed ID: 6416701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Directed chemotherapy in superficial carcinoma of the bladder conditioned by the knowledge of recurrence factors].
    Oliver F; Llopis B; Vera C; Domínguez C; Vidal J; Gallego J; Jiménez JF
    Actas Urol Esp; 1989; 13(1):41-3. PubMed ID: 2496584
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transurethral resection and intravesical therapy of superficial bladder tumors.
    Herr HW
    Urol Clin North Am; 1991 Aug; 18(3):525-8. PubMed ID: 1877115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese Urological Cancer Research Group for Adriamycin.
    Akaza H; Koiso K; Kotake T; Matsumura Y; Isaka S; Machida T; Obata K; Ohashi Y; Ohe H; Ohi Y
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S15-20. PubMed ID: 1394810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results.
    Ueda T; Iguchi A; Sagiyama K; Osada Y; Ariyoshi A; Omoto T; Kumazawa J
    Cancer Chemother Pharmacol; 1987; 20 Suppl():S81-4. PubMed ID: 3664948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravesical therapy for bladder cancer.
    Soloway MS
    Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.